AAD 2025: Advancements in Dermatology : Episode 6
Opinion
Video
From AAD 2025 to the Future: Advancements in Dermatology to Watch
A panelist discusses how the evolving landscape of atopic dermatitis treatment is moving toward a more personalized approach that carefully balances efficacy goals with safety considerations, incorporating new targeted therapies alongside traditional options while also expressing excitement about emerging research in dermatology including novel bispecific antibodies, microbiome-based interventions, and noninvasive diagnostic technologies that may revolutionize disease management in the coming years.
- How do you envision the treatment of atopic dermatitis evolving, particularly regarding the balance between efficacy, safety, and patient management?
- Please discuss any other data in the scope of dermatology released at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) that you find noteworthy to share with colleagues.
- Outside of AAD 2025, what ongoing research efforts are you most excited for in the treatment and management of dermatologic conditions? What can we look forward to through the end of the year and beyond?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
